CELLDEX THERAPEUTICS INC NEW's ticker is CLDXXXXX and the CUSIP is 15117B103. A total of 129 filers reported holding CELLDEX THERAPEUTICS INC NEW in Q3 2017. The put-call ratio across all filers is 0.95 and the average weighting 0.8%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2018 | $2,000 | 0.0% | 4,000 | 0.0% | 0.00% | 0.0% |
| Q2 2018 | $2,000 | -77.8% | 4,000 | 0.0% | 0.00% | -66.7% |
| Q1 2018 | $9,000 | -18.2% | 4,000 | 0.0% | 0.00% | -25.0% |
| Q4 2017 | $11,000 | 0.0% | 4,000 | 0.0% | 0.00% | -20.0% |
| Q3 2017 | $11,000 | +10.0% | 4,000 | 0.0% | 0.01% | 0.0% |
| Q2 2017 | $10,000 | -28.6% | 4,000 | 0.0% | 0.01% | -28.6% |
| Q1 2017 | $14,000 | 0.0% | 4,000 | 0.0% | 0.01% | 0.0% |
| Q4 2016 | $14,000 | – | 4,000 | – | 0.01% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Byrne Asset Management LLC | 86 | $2,000 | 0.00% |